Cymbalta (duloxetine delayed-release capsules), Prescribing Information Link: Prescribing Information, Patient Information or Medication Guide Link
HIGHLIGHTS OF PRESCRIBING INFORMATION Use of CYMBALTA within 14 days of stopping an MAOI . These highlights do not include all the information needed to use. antidepressant is contraindicated . CYMBALTA safely and effectively. See full prescribing In linezolid-or intravenous methylene blue- treated patients, information for CYMBALTA.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CYMBALTA safely and effectively. See full prescribing information for CYMBALTA. CYMBALTA (duloxetine hydrochloride) capsule, delayed release for oral use Initial U.S. Approval: 2024
CYMBALTA safely and effectively. See full prescribing initiation of CYMBALTA is contraindicated (4) information for CYMBALTA. CYMBALTA (duloxetine delayed
See full prescribing information for CYMBALTA. CYMBALTA (duloxetine delayed-release capsules), for
HIGHLIGHTS OF PRESCRIBING INFORMATION Use of CYMBALTA within 14 days of stopping an MAOI . These highlights do not include all the information needed to use. antidepressant is contraindicated . CYMBALTA safely and effectively. See full prescribing In linezolid-or intravenous methylene blue- treated patients, information for CYMBALTA.
See full prescribing information for CYMBALTA. CYMBALTA (duloxetine delayed-release capsules), for
HIGHLIGHTS OF PRESCRIBING INFORMATION Use of CYMBALTA within 14 days of stopping an MAOI . These highlights do not include all the information needed to use. antidepressant is contraindicated . CYMBALTA safely and effectively. See full prescribing In linezolid-or intravenous methylene blue- treated patients, information for CYMBALTA.
Cymbalta (Duloxetine). Clinical Edit Information Included in this Cymbalta Prescribing Information. Indianapolis, IN: Lilly USA, LLC
Comments
SHOULD BE:
Andy had literally simply RELAYED all the various information.